Durable left ventricular assist devices in pediatrics: impact of body size on outcomes and size limitations

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Journal of Artificial Organs

• Publication date

  2024-09-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10047-024-01467-7PMID 39240401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective multicenter feasibility study of a miniaturized implantable continuous flow ventricular assist device in smaller children with heart failure.

  2024cited by this paper
• Preoperative Computed Tomography Virtual Simulation for HeartMate 3 Implantation in Small Children

  2024influential reference
• Long-term Implantable Ventricular Assist Device Support in Children.

  2023cited by this paper
• Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis

  2023cited by this paper
• Successful Implantation of HeartMate3 in a Small Child After Multimodality Imaging Pathway to Assess Feasibility

  2023influential reference
• Expanding Use of the HeartMate 3 Ventricular Assist Device in Pediatric and Adult Patients within the Advanced Cardiac Therapies Improving Outcomes Network (ACTION).

  2023influential reference
• Gastrointestinal bleeding on continuous‐flow left ventricular assist device therapy

  2023cited by this paper
• Impact of Weight on Ventricular Assist Device Outcomes in Dilated Cardiomyopathy Patients in Pediatric Centers: An ACTION Registry Study

  2023influential reference
• Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.

  2022cited by this paper
• HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations.

  2022cited by this paper
• Virtual Simulated Implantation of an Adult-Sized Left Ventricular Assist Device in a Pediatric Patient

  2022influential reference
• HeartWare HVAD Market Withdrawal and Impact on the Pediatric Field.

  2021influential reference
• Berlin Heart EXCOR and ACTION post-approval surveillance study report.

  2021cited by this paper
• Fifth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report.

  2021cited by this paper
• Using virtual reality simulated implantation for fit-testing pediatric patients for adult ventricular assist devices

  2020cited by this paper
• Durable circulatory support with a paracorporeal device as an option for pediatric and adult heart failure patients.

  2020cited by this paper
• Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis.

  2020cited by this paper
• Food and Drug Administration Malfunction Recalls of Left Ventricular Assist Devices

  2020cited by this paper
• Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

  2018influential reference
• Third Generation Ventricular Assist Device: Mid‐Term Outcomes of the HeartWare HVAD in Pediatric Patients

  2018influential reference
• Closing in on the PumpKIN Trial of the Jarvik 2015 Ventricular Assist Device.

  2017influential reference
• Design concepts and principle of operation of the HeartWare ventricular assist system.

  2010cited by this paper
• The society of thoracic surgeons.

  1976influential reference

• Limitations of ventricular assist devices in pediatrics: When one size does not fit all

  2026influential citation